Interojo Inc. (KOSDAQ:119610)
18,510
-70 (-0.38%)
Feb 9, 2026, 9:42 AM KST
Interojo Market Cap
Interojo has a market cap or net worth of 212.07 billion as of February 6, 2026. Its market cap has decreased by -50.14% in one year.
Market Cap
212.07B
Enterprise Value
241.03B
Revenue
109.28B
Ranking
n/a
PE Ratio
72.65
Stock Price
18,510.00
Market Cap Chart
Since July 28, 2010, Interojo's market cap has increased from 44.29B to 212.07B, an increase of 378.83%. That is a compound annual growth rate of 10.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 212.07B | 16.05% |
| Dec 30, 2025 | 182.73B | -53.77% |
| Dec 28, 2023 | 395.31B | 11.81% |
| Dec 29, 2022 | 353.55B | -0.83% |
| Dec 30, 2021 | 356.49B | 45.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.21T |
| Celltrion | 48.14T |
| ALTEOGEN | 19.31T |
| Sam Chun Dang Pharm. | 11.63T |
| HLB Pharmaceutical | 218.78B |
| AptaBio Therapeutics | 216.32B |
| Vieworks | 216.25B |
| REYON Pharmaceutical | 212.57B |